Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com

Aim: Although some sex differences in stroke have been reported, differences in the effects of antiplatelet therapy for secondary stroke prevention have not been clarified. Methods: In the Cilostazol Stroke Prevention Study combination trial, patients with high-risk, non-cardioembolic ischemic strok...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshino, Haruhiko, Toyoda, Kazunori, Omae, Katsuhiro, Takahashi, Kaito, Uchiyama, Shinichiro, Kimura, Kazumi, Yamaguchi, Keiji, Minematsu, Kazuo, Origasa, Hideki, Yamaguchi, Takenori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244066/
https://www.ncbi.nlm.nih.gov/pubmed/36070920
http://dx.doi.org/10.5551/jat.63660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244066/
https://www.ncbi.nlm.nih.gov/pubmed/36070920
http://dx.doi.org/10.5551/jat.63660

Ejemplares similares